Email This Article

High Hopes for Merck, Schering-Plough
By Robert Steyer
03/16/05 - 01:51 PM EST
The struggling drugmakers may score a victory with their novel anticholesterol drug Vytorin.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)
Dow Jones S&P 500 NASDAQ 10-Year Note
10,206.39 1,088.30 2,142.36 34.61
Oil *
76.63
DOWN
20.55
DOWN
4.77
DOWN
11.70
DOWN
0.25
10 Yr
3.46%
SPDR Gold
107.89
-0.20%
-0.44%
-0.54%
-0.72%
Data delayed 20 minutes

Brokerage Partners